IGEM Therapeutics Announces Final Close of £5 million Series A Financing Round
November 30, 2018
New investors Alsa Holdings and UCL Technology Fund join Epidarex Capital Proceeds will allow IGEM to continue development of IgE therapeutic antibody portfolio and novel